Cargando…
Building Genetic Medicine : Breast Cancer, Technology, and the Comparative Politics of Health Care.
Annotation.
| Clasificación: | Libro Electrónico |
|---|---|
| Autor principal: | |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
Cambridge :
MIT Press,
Jan. 2012.
|
| Colección: | Inside Technology Ser.
|
| Temas: | |
| Acceso en línea: | Texto completo |
MARC
| LEADER | 00000cam a2200000Mi 4500 | ||
|---|---|---|---|
| 001 | EBOOKCENTRAL_ocn881121245 | ||
| 003 | OCoLC | ||
| 005 | 20240329122006.0 | ||
| 006 | m o d | ||
| 007 | cr cnu---mpcbr | ||
| 008 | 111015e20120113riu o 000 0 eng | ||
| 040 | |a AU@ |b eng |e pn |c AU@ |d EBLCP |d OCLCQ |d DEBBG |d ZCU |d MERUC |d ICG |d AU@ |d OCLCO |d OCLCF |d OCLCQ |d DKC |d OCLCQ |d TPA |d OCLCO |d OCLCL | ||
| 019 | |a 1296080442 | ||
| 020 | |a 0262517477 | ||
| 020 | |a 9780262517478 | ||
| 020 | |a 0262162423 | ||
| 020 | |a 9780262162425 | ||
| 020 | |a 9780262281287 | ||
| 020 | |a 0262281287 | ||
| 020 | |z 9780262517478 | ||
| 029 | 0 | |a AU@ |b 000052939262 | |
| 029 | 1 | |a DEBBG |b BV044104934 | |
| 035 | |a (OCoLC)881121245 |z (OCoLC)1296080442 | ||
| 043 | |a n-us--- |a e-uk--- | ||
| 050 | 4 | |a RC268.44.B73P37 2012 | |
| 082 | 0 | 4 | |a 362.19604207 |2 23 |
| 049 | |a UAMI | ||
| 100 | 1 | |a Parthasarathy, Shobita. | |
| 245 | 1 | 0 | |a Building Genetic Medicine : |b Breast Cancer, Technology, and the Comparative Politics of Health Care. |
| 260 | |a Cambridge : |b MIT Press, |c Jan. 2012. | ||
| 300 | |a 1 online resource | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 490 | 1 | |a Inside Technology Ser. | |
| 520 | 8 | |a Annotation. |b In Building Genetic Medicine, Shobita Parthasarathy shows how, even in an era of globalization, national context is playing an important role in the developmentand use of genetic technologies. Focusing on the development and deployment of genetic testing forbreast and ovarian cancer (known as BRCA testing) in the United States and Britain, Parthasarathydevelops a comparative analysis framework in order to investigate how national "toolkits"shape both regulations and the architectures of technologies and uses this framework to assess theimplications of new genetic technologies. Parthasarathy argues that differences in the American andBritish approaches to health care and commercialization of research led to the establishment ofdifferent BRCA services in the two countries. In Britain, the technology was available through theNational Health Service as an integrated program of counseling and laboratory analysis, and wasviewed as a potentially cost-effective form of preventive care. In the United States, although BRCAtesting was initially offered by a number of providers, one company eventually became the soleprovider of a test available to consumers on demand. Parthasarathy draws lessons for the future ofgenetic medicine from these cross-national differences, and discusses the ways in which comparativecase studies can inform policy-making efforts in science and technology. | |
| 505 | 0 | |a Toolkits for genetic testing -- Comparative architectures of genetic testing -- Eliminating the competition and ensuring success -- Defining a good health outcome -- Myriad, Britain, and culture clash. | |
| 590 | |a ProQuest Ebook Central |b Ebook Central Academic Complete | ||
| 650 | 0 | |a BRCA genes |x Diagnostic use |z United States. | |
| 650 | 0 | |a BRCA genes |x Diagnostic use |z Great Britain. | |
| 650 | 0 | |a Genetic screening |x Social aspects |z United States. | |
| 650 | 0 | |a Genetic screening |x Social aspects |z Great Britain. | |
| 650 | 0 | |a Breast |x Cancer |x Diagnosis |x Social aspects |z United States. | |
| 650 | 0 | |a Breast |x Cancer |x Diagnosis |x Social aspects |z Great Britain. | |
| 650 | 6 | |a Gènes BRCA |x Utilisation diagnostique |z États-Unis. | |
| 650 | 6 | |a Gènes BRCA |x Utilisation diagnostique |z Grande-Bretagne. | |
| 650 | 6 | |a Dépistage génétique |x Aspect social |z États-Unis. | |
| 650 | 6 | |a Dépistage génétique |x Aspect social |z Grande-Bretagne. | |
| 650 | 7 | |a Breast |x Cancer |x Diagnosis |x Social aspects. |2 fast |0 (OCoLC)fst01767187 | |
| 650 | 7 | |a Genetic screening |x Social aspects. |2 fast |0 (OCoLC)fst00940096 | |
| 651 | 7 | |a Great Britain. |2 fast |0 (OCoLC)fst01204623 |1 https://id.oclc.org/worldcat/entity/E39PBJdmp7p3cx8hpmJ8HvmTpP | |
| 651 | 7 | |a United States. |2 fast |0 (OCoLC)fst01204155 |1 https://id.oclc.org/worldcat/entity/E39PBJtxgQXMWqmjMjjwXRHgrq | |
| 758 | |i has work: |a Building genetic medicine (Text) |1 https://id.oclc.org/worldcat/entity/E39PCFwrtQYMfXjtH9DdcfbFBq |4 https://id.oclc.org/worldcat/ontology/hasWork | ||
| 830 | 0 | |a Inside Technology Ser. | |
| 856 | 4 | 0 | |u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=3338479 |z Texto completo |
| 938 | |a EBL - Ebook Library |b EBLB |n EBL3338479 | ||
| 994 | |a 92 |b IZTAP | ||